Tokyo Tape
Sign in
← Takara Holdings

Quarterly report · Q2

2531.TEDINET S100PIJL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥164.3bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥300.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥141.2bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥19.6bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥21.6bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥20.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥43.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.9bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥20.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥20.4bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥10.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥20.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.1bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.8bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥14.4bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥366.3bnat 2022-09-30Cons.Assets
Total assets¥362.4bnat 2022-03-31Cons.Assets
Total assets¥328.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥122.0bnat 2022-09-30Cons.Liabilities
Total liabilities¥137.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥244.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥224.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥205.8bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥67.1bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥80.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥56.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥75.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥58.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥7.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥16.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥21.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥4.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥552022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.482022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.052021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.842021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.782021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio49.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥6.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥216m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥63.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥63.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥121m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.7bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2022-04-01 → 2022-09-30¥10.9bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥61.8bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥61.3bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥483m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥158.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥157.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥608m
—segment totalsegment profit2022-04-01 → 2022-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥173.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥164.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥19.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥14.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥5.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥8.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥9.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥9.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥93m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2021-04-01 → 2021-09-30¥46.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2021-04-01 → 2021-09-30¥46.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥170m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2021-04-01 → 2021-09-30¥4.3bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2021-04-01 → 2021-09-30¥31.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2021-04-01 → 2021-09-30¥31.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2021-04-01 → 2021-09-30¥14.1bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2021-04-01 → 2021-09-30¥57.6bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2021-04-01 → 2021-09-30¥57.2bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥431m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.3bn
—segment totalrevenue2021-04-01 → 2021-09-30¥135.9bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥135.3bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥601m
—segment totalsegment profit2021-04-01 → 2021-09-30¥20.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥150.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥141.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥9.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥21.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 524
ItemContextValueUnit
Non operating incomeCurrentYTDDuration898000000JPY
Interest expenses noePrior1YTDDuration160000000JPY
Interest expenses noeCurrentYTDDuration149000000JPY
Equity in losses of affiliates noePrior1YTDDuration54000000JPY
Equity in losses of affiliates noeCurrentYTDDuration113000000JPY
Foreign exchange losses noePrior1YTDDuration7000000JPY
Foreign exchange losses noeCurrentYTDDuration113000000JPY
Other noePrior1YTDDuration177000000JPY
Other noeCurrentYTDDuration163000000JPY
Non operating expensesPrior1YTDDuration400000000JPY
Non operating expensesCurrentYTDDuration539000000JPY
Ordinary incomePrior1YTDDuration21884000000JPY
Ordinary incomeCurrentYTDDuration19972000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration80000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration252000000JPY
Insurance income eiPrior1YTDDuration100000000JPY
Insurance income eiCurrentYTDDuration652000000JPY
State subsidy eiPrior1YTDDuration1188000000JPY
State subsidy eiCurrentYTDDuration63000000JPY
Extraordinary incomePrior1YTDDuration1368000000JPY
Extraordinary incomeCurrentYTDDuration967000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration97000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration45000000JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration1188000000JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration63000000JPY
Loss on product recalls elPrior1YTDDuration1567000000JPY
Loss on product recalls elCurrentYTDDuration－JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration16000000JPY
Extraordinary lossPrior1YTDDuration2853000000JPY
Extraordinary lossCurrentYTDDuration125000000JPY
Income before income taxesPrior1YTDDuration20400000000JPY
Income before income taxesCurrentYTDDuration20815000000JPY
Income taxes currentPrior1YTDDuration6396000000JPY
Income taxes currentCurrentYTDDuration5405000000JPY
Income taxes deferredPrior1YTDDuration-354000000JPY
Income taxes deferredCurrentYTDDuration580000000JPY
Income taxesPrior1YTDDuration6041000000JPY
Income taxesCurrentYTDDuration5985000000JPY
Profit lossPrior1YTDDuration14358000000JPY
Profit lossCurrentYTDDuration14829000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration4308000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration3956000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration10050000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration10873000000JPY
Profit lossPrior1YTDDuration14358000000JPY
Profit lossCurrentYTDDuration14829000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration355000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1113000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration10000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass